57 results
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
27 Feb 24
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company’s Sarcoma Franchise
8:13am
, supplier or customer of the PLC and/or any of its subsidiaries or affiliates to the material disadvantage or detriment of the PLC and/or any of its … and styles, product development plans, customer lists, investors, and all papers, resumes and records (including computer records) of the documents containing
8-K
EX-10.1
2zvs90o7nfm3bo
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
8-K
EX-10.01
9lw284wi7w hn5jgf
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am
8-K
EX-10.1
kvt5x0gg
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
S-3ASR
EX-1.2
gq2 e7zg73elq7dpl183
10 Aug 20
Automatic shelf registration
5:01pm
8-K
EX-1.1
sagqlx8
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
8-K
EX-10.1
nviyvqaw4
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am